Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioXcel Therapeutics (BTAI) Current Taxes (2022 - 2025)

Historic Current Taxes for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to $103000.0.

  • BioXcel Therapeutics' Current Taxes rose 4507.04% to $103000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $103000.0, marking a year-over-year increase of 4507.04%. This contributed to the annual value of $91000.0 for FY2024, which is 2155.17% down from last year.
  • BioXcel Therapeutics' Current Taxes amounted to $103000.0 in Q3 2025, which was up 4507.04% from $108000.0 recorded in Q2 2025.
  • BioXcel Therapeutics' 5-year Current Taxes high stood at $529000.0 for Q3 2022, and its period low was $65000.0 during Q1 2025.
  • Moreover, its 4-year median value for Current Taxes was $108000.0 (2025), whereas its average is $162200.0.
  • In the last 5 years, BioXcel Therapeutics' Current Taxes tumbled by 7485.82% in 2023 and then surged by 5428.57% in 2025.
  • Over the past 4 years, BioXcel Therapeutics' Current Taxes (Quarter) stood at $82000.0 in 2022, then surged by 41.46% to $116000.0 in 2023, then decreased by 21.55% to $91000.0 in 2024, then grew by 13.19% to $103000.0 in 2025.
  • Its Current Taxes stands at $103000.0 for Q3 2025, versus $108000.0 for Q2 2025 and $65000.0 for Q1 2025.